Grade 2 Hearing Patients without Baseline Audiogram and Not Enrolled in a Monitoring Program, CTCAE

MedGen UID:: 288006
•Concept ID:: C1560167
•: Finding

Synonym:

CTCAE Grade 2 Hearing: patients without baseline audiogram and not enrolled in a monitoring program

Term Hierarchy

GTR
MeSH

CClinical test, RResearch test, OOMIM, GGeneReviews, VClinVar

CROGVGrade 2 Hearing Patients without Baseline Audiogram and Not Enrolled in a Monitoring Program, CTCAE

Clinical finding
- Finding by Cause
  - Adverse Event
    - Adverse Event by CTCAE Category
      - Adverse Event Associated with the Ear and Auditory System
        Hearing Patients without Baseline Audiogram and Not Enrolled in a Monitoring Program, CTCAE
        Grade 2 Hearing Patients without Baseline Audiogram and Not Enrolled in a Monitoring Program, CTCAE

Professional guidelines

PubMed

Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population.

Chan SL, Ng LS, Goh X, Siow CH, Goh HL, Goh BC, Cheo T, Loh KS, Brunham LR
Head Neck 2018 Jul;40(7):1425-1433. Epub 2018 Feb 16 doi: 10.1002/hed.25112. PMID: 29451951

See all (1)

MedGen

National Center for Biotechnology Information

Send to:

Grade 2 Hearing Patients without Baseline Audiogram and Not Enrolled in a Monitoring Program, CTCAE

Term Hierarchy

Professional guidelines

PubMed

Supplemental Content

Table of contents

Practice guidelines

Recent activity